Aquaxis Law Office

M&A, Corporate, Commercial Transactions, Litigation and Dispute Resolution, Pharmaceuticals and Medical Devices

Partner

2024 November – present – I-ne Co., Ltd., Special Advisor 2023 July – present – Aquaxis Law Office 2020 – 2023 June – Sonderhoff & Einsel, Law and Patent Office 2017 – 2020 – Sojitz Corporation, Corporate Officer & COO, M&A Management Office and Controller’s Office 2018 – 2019 – LINE Corporation, Corporate Auditor 2011 – 2017 – K&L Gates Gaikokuho Joint Enterprise, Partner 2001 – 2011 – Clifford Chance Law Office, Partner 1991 – 2001 – Tanaka & Takahashi Law Officen, Attorney

Other Services

2017 – present – Global Health Innovative Technology Fund, Board Advisor 2016 – present – Keio Law School, Academic Advisory Board Member 2013 – present – Japan Pharmaceutical Industry Legal Affairs Association, International Affairs Working Group, Advisor 2010 – 2013 – Keio Law School, Lecturer 2010 – present – Tokyo Small-claim Court, Mediator 2010 – 2017 – Nihon L’Oreal K.K. Ethical Review Board Member 2008 – 2017 – Mundipharma Japan KK., Internal Clinical Trial Review Board, Member 2004 – present – Dai-ni Tokyo Bar Association, Arbitration Center, Arbitrator

Japanese and English

Dai-ni Tokyo Bar Association (1991) Chartered Institute of Arbitration, Member (MCIArb)

1996 – Duke University School of Law (LL.M.) 1986 – Keio University (LL.B.) ― Japan Corporate Governance Network, Director’s University, Master of Independent Director (MID) Tokyo Medical and Dental University Interdisciplinary Life Science Consortium, Medical Innovation Talent Development Program (diploma) Tsukuba Clinical Research & Development Organization (T-CReDO),　University of Tsukuba Graduate School of Comprehensive Human Science, Regulatory Science Program (diploma)